Early reversal of pediatric-neonatal septic shock by community physicians is associated with improved outcome

被引:397
作者
Han, YY
Carcillo, JA
Dragotta, MA
Bills, DM
Watson, RS
Westerman, ME
Orr, RA
机构
[1] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA
[3] Childrens Hosp Pittsburgh, Dept Crit Care Med Transport, Pittsburgh, PA 15213 USA
关键词
fluid resuscitation; inotropes; interfacility transport; hydrocortisone;
D O I
10.1542/peds.112.4.793
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. Experimental and clinical studies of septic shock support the concept that early resuscitation with fluid and inotropic therapies improves survival in a time-dependent manner. The new American College of Critical Care Medicine-Pediatric Advanced Life Support (ACCM-PALS) Guidelines for hemodynamic support of newborns and children in septic shock recommend this therapeutic approach. The objective of this study was to determine whether early septic shock reversal and use of resuscitation practice consistent with the new ACCM-PALS Guidelines by community physicians is associated with improved outcome. Methods. A 9-year (January 1993-December 2001) retrospective cohort study was conducted of 91 infants and children who presented to local community hospitals with septic shock and required transport to Children's Hospital of Pittsburgh. Shock reversal (defined by return of normal systolic blood pressure and capillary refill time), resuscitation practice concurrence with ACCM-PALS Guidelines, and hospital mortality were measured. Results. Overall, 26 (29%) patients died. Community physicians successfully achieved shock reversal in 24 (26%) patients at a median time of 75 minutes (when the transport team arrived at the patient's bedside), which was associated with 96% survival and >9-fold increased odds of survival (9.49 [1.07-83.89]). Each additional hour of persistent shock was associated with >2-fold increased odds of mortality (2.29 [1.19-4.44]). Nonsurvivors, compared with survivors, were treated with more inotropic therapies (dopamine/dobutamine [42% vs 20%] and epinephrine/norepinephrine [42% vs 6%]) but not increased fluid therapy (median volume; 32.9 mL/kg vs 20.0 mL/kg). Resuscitation practice was consistent with ACCM-PALS Guidelines in only 27 (30%) patients; however, when practice was in agreement with guideline recommendations, a lower mortality was observed (8% vs 38%). Conclusions. Early recognition and aggressive resuscitation of pediatric-neonatal septic shock by community physicians can save lives. Educational programs that promote ACCM-PALS recommended rapid, stepwise escalations in fluid as well as inotropic therapies may have value in improving outcomes in these children.
引用
收藏
页码:793 / 799
页数:7
相关论文
共 19 条
  • [1] Ability of hospitals to care for pediatric emergency patients
    Athey, J
    Dean, JM
    Ball, J
    Wiebe, R
    Melese-d'Hospital, I
    [J]. PEDIATRIC EMERGENCY CARE, 2001, 17 (03) : 170 - 174
  • [2] Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery
    Booy, R
    Habibi, P
    Nadel, S
    de Munter, C
    Britto, J
    Morrison, A
    Levin, M
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2001, 85 (05) : 386 - 390
  • [3] ROLE OF EARLY FLUID RESUSCITATION IN PEDIATRIC SEPTIC SHOCK
    CARCILLO, JA
    DAVIS, AL
    ZARITSKY, A
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (09): : 1242 - 1245
  • [4] Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock
    Carcillo, JA
    Fields, AI
    [J]. CRITICAL CARE MEDICINE, 2002, 30 (06) : 1365 - 1378
  • [5] CHUNG TW, 1991, CIRC SHOCK, V33, P178
  • [6] DOBKIN ED, 1985, CIRC SHOCK, V16, P325
  • [7] HOBAN LD, 1991, CIRC SHOCK, V34, P252
  • [8] Endocrine and metabolic responses in children with meningoccocal sepsis: Striking differences between survivors and nonsurvivors
    Joosten, KFM
    De Kleijn, ED
    Westerterp, M
    De Hoog, M
    Eijck, FCV
    Hop, WCJ
    Voort, EV
    Hazelzet, JA
    Hokken-Koelega, ACS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) : 3746 - 3753
  • [9] MCEVOY GK, 2002, AM HOSP FORMULARY SE, P2931
  • [10] Nadel S, 1998, J ACCID EMERG MED, V15, P298